Developers Taconic Investment Partners and Silverstein Properties are spending $20 million to renovate the 326,861-sf Movie Lab building in Midtown Manhattan for life science research usage.
The New York Post reports that the Stem Cell Foundation has leased 42,100 sf in this building since 2015. Another 150,000 sf on the top floors of this 10-story building are being upgraded to attract more life science tenants. The building reportedly is changing its name to the Hudson Research Center.
Transwestern, which is marketing this lab space for the developers, has released a special report that portrays New York City as an emerging life sciences hub, where space is tight and development opportunities are multiplying.
New York is already a significant player in this field, by virtue of being home to 11 major academic medical centers, including Weill Cornell Medical College and Albert Einstein College of Medicine. The city also has three of the country’s top 15 hospitals and five of the top 50 medical schools, according to U.S. News and World Report’s latest report card.
New York City is already a leader in life sciences employment and, more recently, available funding. Image: Transwestern
The city also one of the country’s highest concentrations of life-science employees, accounting for one-fifth of the total employment in this sector within the top 10 life science markets.
The problem is shortage of lab space. Transwestern estimates that 100% of the city’s 1.7 million sf of existing life science and research space is occupied. And until recently, New York’s zoning restrictions made it particularly tough for life science companies to build lab space within manufacturing districts—M Zones—that restrict chemical compounding and packaging, the creation of pharmaceutical products and medical appliances, laboratories, research, experimental and testing facilities.
But over the past year or so, market and regulatory changes have made development more conducive for lab science expansion.
Indeed, recent lease transactions have included 49,143 sf at 10 Hudson Yards for Intercept Pharmaceuticals, 30,000 sf at 101 Avenue of the Americas for JLABS (division of J&J Innovations), 19,645 sf at 100 Wall Street for Integra Partners, 11,865 sf at 600 Third Avenue for Turing Pharmaceuticals, and 11,537 sf at 25 West 45th Street for Crossover Health.
More investment capital and funding are flowing into the city for this sector. Out of the $31.3 billion in National Institutes of Health funding awarded nationally in 2016, the New York metro area received $2.7 billion in NIH grants. New York City alone was awarded $1.4 billion, ranking it the second-highest funded city in the country.
More dollars from the National Institutes of Health are flowing into New York State and, particularly, New York City. Image: NIH/Transwestern
Last December, New York Governor Andrew Cuomo unveiled a state-funded life science initiative that includes $250 million in tax incentives for new and existing life science companies, $200 million in state capital grants to further support investment in wet-lab and innovation space, $100 million in investment capital for early stage life science initiatives, and a state match of at least $100 million for operating support from private sector partnerships.
New York City Mayor Bill DiBlasio also has launched a program called LifeSci NYC, which will include a $100 million investment to create a new applied life science campus, $50 million to expand a network of life science R&D facilities, $10 million to expand the network of incubators, $20 million a year in matching funds to support early-stage businesses, and $300 million in tax incentives for commercial lab space.
On the zoning front, in December the Departments of Buildings (DOB) and City Planning (DCP), and the Economic Development Corporation (EDC) issued a clarification memo updating their interpretation of the zoning in the several commercial districts.
The city agencies and the EDC, says Transwestern, “broadened their understanding of the current use group 9A zoning to also include the “synthesis and manipulation of chemical substances, biological matter, and animal models … [that] are integral activities in commercial medical laboratories devoted to research and testing.”
Already, new research and lab spaces are popping up. The Cornell Tech campus on New York City’s Roosevelt Island just opened its first phase. And the 1.17-million-sf Building 77 at the Brooklyn Navy Yard is undergoing a $185 million renovation that could attract lab tenants.
Related Stories
Laboratories | Sep 22, 2017
Designing for how we learn: Maker spaces and instructional laboratories
Here is how the See + Hear + Do = Remember mantra can be applied to maker spaces and instructional labs.
Laboratories | Aug 3, 2017
Today’s university lab building by the numbers
A three-month study of science facilities conducted by Shepley Bulfinch reveals key findings related to space allocation, size, and cost.
Laboratories | Jul 18, 2017
Pfizer breaks ground on new R&D campus in St. Louis suburb
The facility will consolidate the company’s local workforce, and provide flexible work and research spaces.
Building Team Awards | Jun 12, 2017
The right prescription: University of North Dakota School of Medicine & Health Sciences
Silver Award: North Dakota builds a new medical/health sciences school to train and retain more physicians.
Laboratories | Apr 13, 2017
How to design transformative scientific spaces? Put people first
While most labs are designed to achieve that basic functionality, a transformational lab environment prioritizes a science organization’s most valuable assets: its people.
Laboratories | Sep 26, 2016
Construction has finished on the world’s largest forensic anthropology lab, designed by SmithGroupJJR
The lab’s main purpose will be to help in the investigation, recovery, and accounting of Americans lost in past wars.
Laboratories | Aug 8, 2016
The lab of the future: smaller, flexible, tech-enabled, business focused
A new CBRE report emphasizes the importance of collaboration and standardization in lab design.
Laboratories | Jun 16, 2016
How HOK achieved design consensus for London's Francis Crick Institute
The 980,000-sf, $931 million facility is the result of a unique financing mechanism that brought together three of the U.K.’s heaviest funders of biomedical research—the Medical Research Council, Cancer Research UK, and the Wellcome Trust—and three leading universities—University College London, Imperial College London, and King’s College London.